ROBIN SHERRINGTON — SEC Form 4 filings

SEC reporting owner CIK 1619962. 2 Form 4 filings on record with FilingPulse; latest filed 2024-03-12.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-03-08 to 2024-03-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Xenon Pharmaceuticals Inc. (XENE)EVP, Strategy & Innovation22 legs · 7,137 sh · $330,2907

Form 4 filings — ROBIN SHERRINGTON

FiledFormIssuerReported transactionsSource
2024-03-124Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-03-084Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 1,234 @ $9.85 · Tax withholding (F): 215 @ $45.96 · Option exercise (M): 7,407 @ $9.85 · Tax withholding (F): 1,289 @ $45.96 · Sale (S): 1,019 @ $46.15 · Sale (S): 6,118 @ $46.30 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1619962 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →